Company Overview Lexaria Bioscience Corp. is a biotechnology company dedicated to the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (APIs) using our patented DehydraTECH TM drug delivery technology. DehydraTECH combines APIs with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerabi...
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-28 | 2025-08-31 | 0001640334-25-002225 | EDGAR | 46K words |
| 2024-11-26 | 2024-08-31 | 0001640334-24-001787 | EDGAR | — |
| 2023-11-20 | 2023-08-31 | 0001640334-23-002227 | EDGAR | — |
| 2022-11-28 | 2022-08-31 | 0001640334-22-002512 | EDGAR | — |
| 2021-11-29 | 2021-08-31 | 0001640334-21-002981 | EDGAR | — |
| 2020-10-15 | 2020-08-31 | 0001640334-20-002561 | EDGAR | — |
| 2019-11-14 | 2019-08-31 | 0001640334-19-002303 | EDGAR | — |
| 2018-11-14 | 2018-08-31 | 0001640334-18-002165 | EDGAR | — |
| 2017-11-27 | 2017-08-31 | 0001062993-17-005078 | EDGAR | — |
| 2016-11-29 | 2016-08-31 | 0001062993-16-012493 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-13 | 2025-11-30 | 0001640334-26-000080 | EDGAR | 18K words |
| 2025-07-14 | 2025-05-31 | 0001640334-25-001195 | EDGAR | — |
| 2025-04-14 | 2025-02-28 | 0001640334-25-000629 | EDGAR | — |
| 2025-01-10 | 2024-11-30 | 0001640334-25-000058 | EDGAR | — |
| 2024-07-12 | 2024-05-31 | 0001640334-24-001091 | EDGAR | — |
| 2024-04-09 | 2024-02-29 | 0001640334-24-000589 | EDGAR | — |
| 2024-01-12 | 2023-11-30 | 0001640334-24-000051 | EDGAR | — |
| 2023-07-14 | 2023-05-31 | 0001640334-23-001286 | EDGAR | — |
| 2023-04-14 | 2023-02-28 | 0001640334-23-000636 | EDGAR | — |
| 2023-01-17 | 2022-11-30 | 0001640334-23-000077 | EDGAR | — |
| 2022-07-14 | 2022-05-31 | 0001640334-22-001505 | EDGAR | — |
| 2022-04-11 | 2022-02-28 | 0001640334-22-000728 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-06 | 0001640334-26-000230 | EDGAR | 1K words |
| 2026-01-28 | 0001640334-26-000162 | EDGAR | — |
| 2025-12-16 | 0001640334-25-002348 | EDGAR | — |
| 2025-09-29 | 0001640334-25-001742 | EDGAR | — |
| 2025-09-25 | 0001640334-25-001717 | EDGAR | — |
| 2025-06-12 | 0001640334-25-001030 | EDGAR | — |
| 2025-04-28 | 0001640334-25-000711 | EDGAR | — |
| 2025-02-05 | 0001640334-25-000192 | EDGAR | — |
| 2025-01-15 | 0001640334-25-000087 | EDGAR | — |
| 2025-01-03 | 0001640334-25-000009 | EDGAR | — |
472 total filings indexed. 440 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001348362 |
| Ticker | LEXX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.lexariabioscience.com |
| Listed | 2006-09-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report